New infant vaccine trial aims to shield babies from deadly pneumonia
NCT ID NCT07593924
First seen May 22, 2026 · Last updated May 22, 2026
Summary
This study tests a new vaccine (PCV13) to protect healthy infants from pneumococcal infections, which can cause pneumonia, meningitis, and ear infections. About 500 babies aged around 2 months will receive either the new vaccine or an existing one to compare safety and immune response. The goal is to see if the new vaccine works as well as the current standard.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMOCOCCAL INFECTIOUS DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Health Index Multispecialty Clinic (HIMC) Research and Development on Medical Sciences
Imus, Cavite, Philippines
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.